CT Financial Advisors’s GSK GSK Stock Holding History

CT Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$228K	Buy	4,333 +4	+0.1%	+$203	0.14%	143
2016 Q4	$208K	Buy	4,329 +800	+23%	+$39.5K	0.13%	146
2016 Q3	$190K	Hold	3,529	–	–	0.12%	152
2016 Q2	$191K	Hold	3,529	–	–	0.12%	149
2016 Q1	$179K	Sell	3,529 -72	-2%	-$3.59K	0.1%	161
2015 Q4	$182K	Hold	3,601	–	–	0.1%	156
2015 Q3	$173K	Sell	3,601 -184	-5%	-$9.58K	0.11%	156
2015 Q2	$197K	Hold	3,785	–	–	0.11%	152
2015 Q1	$218K	Hold	3,785	–	–	0.12%	144
2014 Q4	$202K	Buy	+3,785	New	+$212K	0.15%	114
2014 Q1	$218K	Buy	+3,785	New	+$256K	0.12%	144

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CT Financial Advisors's GSK Position: Q1 2017 in Review

CT Financial Advisors increased its GSK (GSK) stake by 0.09% in Q1 2017, buying an estimated $203 and bringing the position to 4,333 shares worth $228K. The position accounts for 0.14% of the portfolio, ranked #143.

CT Financial Advisors first reported a position in GSK in Q1 2014 and has held it in 11 quarters since. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

CT Financial Advisors held 4,333 shares of GSK worth $228K as of Q1 2017.
CT Financial Advisors bought 4 GSK shares in Q1 2017, an estimated $203.
GSK made up 0.14% of CT Financial Advisors's portfolio in Q1 2017, its #143 holding.
CT Financial Advisors first reported a position in GSK in Q1 2014 and has held it in 11 quarters since.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.